Search Results - "Gurary, Ellen B"

Randomized Controlled Trial of Social Media: Effect of Increased Intensity of the Intervention by Fox, Caroline S., Gurary, Ellen B., Ryan, John, Bonaca, Marc, Barry, Karen, Loscalzo, Joseph, Massaro, Joseph

“…Background A prior randomized controlled trial of social media exposure at Circulation determined that social media did not increase 30‐day page views. Whether…”
Get full text

Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib by Kudo, Masatoshi, Finn, Richard S., Edeline, Julien, Cattan, Stéphane, Ogasawara, Sadahisa, Palmer, Daniel H., Verslype, Chris, Zagonel, Vittorina, Fartoux, Laetitia, Vogel, Arndt, Sarker, Debashis, Verset, Gontran, Chan, Stephen L., Knox, Jennifer, Daniele, Bruno, Yau, Thomas, Gurary, Ellen B., Siegel, Abby B., Wang, Anran, Cheng, Ann-Lii, Zhu, Andrew X.

“…Pembrolizumab, a PD-1 inhibitor, demonstrated anti-tumour activity and tolerability in patients treated with sorafenib and with advanced hepatocellular…”
Get full text

Parental non‐alcoholic fatty liver disease increases risk of non‐alcoholic fatty liver disease in offspring by Long, Michelle T., Gurary, Ellen B., Massaro, Joseph M., Ma, Jiantao, Hoffmann, Udo, Chung, Raymond T., Benjamin, Emelia J., Loomba, Rohit

“…Background & Aims Little is known regarding the risk of hepatic steatosis (HS) among adult children of affected parents. We examined the association between…”
Get full text

Olaparib with or without bevacizumab or bevacizumab and 5-fluorouracil in advanced colorectal cancer: Phase III LYNK-003 by Kim, Tae Won, Taieb, Julien, Gurary, Ellen B, Lerman, Nati, Cui, Karen, Yoshino, Takayuki

“…Oxaliplatin-based chemotherapy with a regimen such as FOLFOX with or without targeted therapy is a standard of care option for advanced colorectal cancer;…”
Get full text

Stage II Oral Tongue Cancer: Survival Impact of Adjuvant Radiation Based on Depth of Invasion by Rubin, Samuel J., Gurary, Ellen B., Qureshi, Muhammad M., Salama, Andrew R., Ezzat, Waleed H., Jalisi, Scharukh, Truong, Minh Tam

“…Objective To determine if adjuvant radiation therapy for patients with pT2N0 oral cavity tongue cancer affects overall survival. Study Design Retrospective…”
Get full text

Cardiac Abnormalities in Patients With Hutchinson-Gilford Progeria Syndrome by Prakash, Ashwin, Gordon, Leslie B, Kleinman, Monica E, Gurary, Ellen B, Massaro, Joseph, D'Agostino, Sr, Ralph, Kieran, Mark W, Gerhard-Herman, Marie, Smoot, Leslie

“…Hutchinson-Gilford progeria syndrome (HGPS) is an ultrarare disorder associated with premature death due to cardiovascular events during the second decade of…”
Get more information

Baseline Range of Motion, Strength, Motor Function, and Participation in Youth with Hutchinson-Gilford Progeria Syndrome by Malloy, Julie, Berry, Emily, Correia, Annette, Fragala-Pinkham, Maria, Coucci, Sarah, Riley, Susan, Spratt, Jessica, Knight Pfaffinger, Jessica, Massaro, Joe, Ehrbar, Rachel, D'Agostino, Ralph, Gurary, Ellen B., Gordon, Leslie B., Kleinman, Monica E.

“…Limited information is available on impairments, activity limitations and participation restrictions in youth with Hutchinson-Gilford progeria syndrome (HGPS),…”
Get full text

Effect of smoking and soft tissue release on risk of revision after total knee arthroplasty: a case- control study by Nwachukwu, Benedict U, Gurary, Ellen B, Lerner, Vladislav, Collins, Jamie E, Thornhill, Thomas S, Losina, Elena, Katz, Jeffrey N

“…Increasing utilization of primary total knee arthroplasty (TKA) is projected to expand demand for revision TKA. Revision TKAs are procedurally complex and…”
Get full text

Olaparib ± bevacizumab versus bevacizumab + fluorouracil in patients with unresectable or metastatic colorectal cancer not progressing on first-line FOLFOX + bevacizumab: Phase III LYNK-003 study by Mayo, Carlos Alberto, Gurary, Ellen B., Marinello, Patricia

“…Abstract only TPS156 Background: Patients with metastatic colorectal cancer (CRC) often receive intensive platinum-based regimens, such as FOLFOX (fluorouracil…”
Get full text

328 Phase 3 study of olaparib ± bevacizumab versus bevacizumab + fluorouracil in patients with unresectable or metastatic colorectal cancer not progressing on first-line FOLFOX + bevacizumab (LYNK-003) by Mayo, Carlos, Gurary, Ellen B, Marinello, Patricia

“…BackgroundPlatinum-based regimens, such as FOLFOX (fluorouracil [5-FU], leucovorin, oxaliplatin), are recommended standard of care first-line options in…”
Get full text

Updated efficacy and safety of KEYNOTE-224: A phase II study of pembrolizumab (pembro) in patients with advanced hepatocellular carcinoma (HCC) by Kudo, Masatoshi, Finn, Richard S., Edeline, Julien, Cattan, Stéphane, Ogasawara, Sadahisa, Palmer, Daniel H., Verslype, Chris, Zagonel, Vittorina, Fartoux, Laetitia, Vogel, Arndt, Sarker, Debashis, Verset, Gontran, Chan, Stephen Lam, Knox, Jennifer J., Daniele, Bruno, Gurary, Ellen B, Siegel, Abby B., Jain, Lokesh, Cheng, Ann-Lii, Zhu, Andrew X.

“…Abstract only 518 Background: Pembro received accelerated approval in pts with advanced HCC in the second-line setting based on results of the KEYNOTE-224…”
Get full text